Chemicals · Founded 1979 · www.alkylamines.com · BSE 506767 · NSE ALKYL AMINES · ISIN INE150B01039
No Notes Added Yet
Business
Alkyl Amines Chemicals Ltd. (AACL) is a leading Indian manufacturer of various specialty chemicals, primarily alkylamines and their derivatives, along with specialty intermediates. The company's core business involves producing essential chemical building blocks that are critical raw materials for a wide range of industries. It makes money by manufacturing these chemicals at its facilities and supplying them to customers in sectors such as pharmaceuticals, agrochemicals, rubber chemicals, dyes & intermediates, water treatment chemicals, and specialty polymers.
Revenue Mix
The company's revenue is primarily derived from two broad categories:
Amines and Amine Derivatives: This forms the largest portion of its revenue, including products like Methylamines (Monomethylamine, Dimethylamine, Trimethylamine), Ethylamines (Monoethylamine, Diethylamine, Triethylamine), and Isopropylamines.
Specialty Chemicals: This segment includes various specialty intermediates and fine chemicals catering to specific customer requirements and niche applications.
While specific revenue percentages for each segment are not typically disclosed in detail, alkylamines and their derivatives represent the bulk of the company's sales.
Industry
Alkyl Amines operates within the Indian chemicals industry, which is characterized by its diversity, high capital intensity, and increasing focus on import substitution. The industry benefits from a large domestic consumption base and government support for local manufacturing. AACL holds a prominent position as one of the largest manufacturers of specific alkylamines (e.g., methylamines, ethylamines) in India, alongside a few other key players. Its integrated manufacturing facilities and focus on backward integration provide it with a competitive edge within its niche. The company also produces specialty chemicals, allowing it to diversify beyond basic amines and cater to higher-value applications.
MOAT
Alkyl Amines possesses several competitive advantages:
Cost Leadership & Scale: As one of the largest producers of key alkylamines in India, it benefits from economies of scale in manufacturing, procurement, and distribution, leading to a cost advantage.
Integrated Operations: The company has undertaken backward integration, which helps manage raw material costs and ensures supply security, reducing dependency on external suppliers.
High Entry Barriers: The chemical manufacturing industry requires significant capital investment, technological expertise, and adherence to stringent environmental regulations, creating high barriers for new entrants.
Established Customer Relationships: Over decades, AACL has built strong relationships with a diverse customer base across various end-user industries, making it a preferred supplier for critical raw materials.
Growth Drivers
Growth in End-User Industries: Sustained growth in sectors like pharmaceuticals, agrochemicals, and specialty polymers in India and globally will drive demand for AACL's products.
Capacity Expansions: The company has been consistently expanding its capacities for existing products and introducing new specialty chemicals, which will contribute to volume growth.
"China Plus One" Strategy / Import Substitution: Global supply chain de-risking initiatives and government policies promoting "Make in India" are leading to increased domestic production and reduced reliance on imports for chemicals, benefiting companies like AACL.
New Product Development: Focus on developing and commercializing new specialty chemicals catering to evolving market needs can unlock new revenue streams and improve margins.
Increased Utilization Rates: As demand grows, higher utilization of existing and expanded capacities will improve operational leverage.
Risks
Raw Material Price Volatility: The company's profitability is susceptible to fluctuations in the prices of key feedstocks (e.g., methanol, ammonia, ethanol), which are largely crude oil derivatives.
Environmental & Regulatory Risks: Stringent environmental regulations and compliance requirements can lead to increased operational costs or potential disruptions if not managed effectively.
Intense Competition: Competition from domestic players and potential imports, especially for commodity amines, can exert pressure on pricing and margins.
Economic Slowdown: A downturn in the global or domestic economy could impact demand from end-user industries, affecting sales volumes.
Project Execution Risk: Delays or cost overruns in ongoing or future capacity expansion projects could impact projected returns.
Management & Ownership
Alkyl Amines is promoted by the Kothari family, who have a long history in the chemicals industry. Mr. Yogesh M. Kothari serves as the Chairman and Managing Director, leading the company for several decades. The management is generally perceived to be experienced and conservative in its approach, focusing on sustainable growth and operational efficiency. The promoter group holds a significant stake in the company, aligning their interests with those of other shareholders.
Outlook
Alkyl Amines is well-positioned to benefit from the growing demand for specialty chemicals in India, driven by robust growth in end-user industries and government impetus for domestic manufacturing. Its established market position, integrated operations, and ongoing capacity expansions provide a solid foundation for future growth. However, the company faces inherent risks associated with raw material price volatility, intense competition, and evolving environmental regulations. The ability of the management to effectively navigate these challenges while capitalizing on growth opportunities, particularly in the higher-margin specialty chemicals segment, will be crucial for its sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Net Sales | 218 | 213 | 237 | 266 | 235 | 257 | 235 |
| Other Income | 0 | 2 | 2 | 1 | 0 | 2 | 3 |
| Total Income | 218 | 215 | 239 | 268 | 235 | 259 | 237 |
| Total Expenditure | 169 | 174 | 199 | 207 | 177 | 184 | 167 |
| Operating Profit | 49 | 40 | 40 | 60 | 58 | 75 | 70 |
| Interest | 4 | 4 | 3 | 4 | 3 | 2 | 2 |
| Depreciation | 6 | 6 | 6 | 6 | 7 | 7 | 7 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 15 | 0 |
| Profit Before Tax | 40 | 31 | 30 | 50 | 49 | 81 | 61 |
| Provision for Tax | 14 | 10 | 13 | 15 | -4 | 22 | 12 |
| Profit After Tax | 26 | 21 | 18 | 35 | 53 | 59 | 49 |
| Adjustments | 1 | 1 | 1 | 2 | 2 | 1 | 0 |
| Profit After Adjustments | 27 | 22 | 19 | 37 | 55 | 60 | 49 |
| Adjusted Earnings Per Share | 5.2 | 4.4 | 3.7 | 7.2 | 10.8 | 11.8 | 9.7 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 236 | 288 | 366 | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 993 |
| Other Income | 2 | 3 | 1 | 2 | 3 | 3 | 1 | 3 | 2 | 6 | 6 |
| Total Income | 238 | 290 | 367 | 448 | 479 | 486 | 502 | 619 | 849 | 999 | 999 |
| Total Expenditure | 205 | 245 | 308 | 361 | 391 | 393 | 405 | 499 | 682 | 736 | 735 |
| Operating Profit | 33 | 45 | 59 | 87 | 89 | 94 | 96 | 121 | 167 | 264 | 263 |
| Interest | 10 | 12 | 13 | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 11 |
| Depreciation | 9 | 9 | 10 | 10 | 11 | 13 | 14 | 17 | 23 | 27 | 27 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 15 |
| Profit Before Tax | 14 | 24 | 36 | 65 | 67 | 73 | 75 | 97 | 133 | 246 | 241 |
| Provision for Tax | 3 | 7 | 12 | 22 | 22 | 23 | 24 | 31 | 46 | 44 | 45 |
| Profit After Tax | 10 | 17 | 24 | 43 | 46 | 50 | 52 | 66 | 86 | 201 | 196 |
| Adjustments | 4 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Profit After Adjustments | 14 | 18 | 24 | 43 | 45 | 50 | 52 | 66 | 86 | 201 | 201 |
| Adjusted Earnings Per Share | 2.7 | 3.5 | 4.7 | 8.5 | 8.9 | 9.8 | 10.2 | 12.9 | 16.9 | 39.5 | 39.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 17% | 26% | 16% | 0% |
| Operating Profit CAGR | 58% | 40% | 24% | 0% |
| PAT CAGR | 134% | 57% | 34% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -8% | -9% | -15% | 30% |
| ROE Average | 44% | 31% | 28% | 26% |
| ROCE Average | 44% | 32% | 29% | 25% |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 85 | 98 | 116 | 150 | 184 | 209 | 256 | 309 | 379 | 537 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 54 | 52 | 60 | 65 | 56 | 45 | 66 | 108 | 79 | 48 |
| Other Non-Current Liabilities | 34 | 30 | 32 | 40 | 45 | 53 | 96 | 128 | 168 | 177 |
| Total Current Liabilities | 99 | 119 | 159 | 179 | 148 | 146 | 161 | 180 | 248 | 154 |
| Total Liabilities | 272 | 299 | 367 | 434 | 434 | 453 | 578 | 725 | 873 | 915 |
| Fixed Assets | 98 | 122 | 126 | 155 | 151 | 187 | 220 | 355 | 376 | 423 |
| Other Non-Current Assets | 64 | 39 | 46 | 45 | 83 | 65 | 133 | 131 | 185 | 198 |
| Total Current Assets | 110 | 138 | 195 | 235 | 200 | 201 | 225 | 238 | 312 | 294 |
| Total Assets | 272 | 299 | 367 | 434 | 434 | 453 | 578 | 725 | 873 | 915 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 1 | 5 | 5 | 12 | 6 | 4 | 1 | 2 | 19 |
| Cash Flow from Operating Activities | 24 | 36 | 22 | 47 | 61 | 101 | 63 | 102 | 144 | 188 |
| Cash Flow from Investing Activities | -17 | -19 | -27 | -27 | -31 | -35 | -65 | -132 | -67 | -41 |
| Cash Flow from Financing Activities | -9 | -13 | 5 | -13 | -36 | -68 | -2 | 32 | -60 | -135 |
| Net Cash Inflow / Outflow | -2 | 4 | 0 | 7 | -6 | -2 | -3 | 2 | 17 | 12 |
| Closing Cash & Cash Equivalent | 1 | 5 | 5 | 12 | 6 | 4 | 1 | 3 | 19 | 31 |
| # | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.74 | 3.45 | 4.75 | 8.49 | 8.85 | 9.81 | 10.16 | 12.94 | 16.89 | 39.48 |
| CEPS(Rs) | 3.83 | 5.17 | 6.66 | 10.4 | 11.17 | 12.33 | 12.96 | 16.25 | 21.46 | 44.76 |
| DPS(Rs) | 0.6 | 0.8 | 1 | 1.6 | 1.6 | 4 | 2 | 2.8 | 3.2 | 8 |
| Book NAV/Share(Rs) | 16.52 | 19.04 | 22.61 | 29.23 | 35.96 | 40.84 | 50.17 | 60.6 | 74.14 | 104.86 |
| Core EBITDA Margin(%) | 12.35 | 13.77 | 14.5 | 17.64 | 16.62 | 17.39 | 17.56 | 18.82 | 19.42 | 25.9 |
| EBIT Margin(%) | 9.45 | 11.71 | 12.36 | 16.08 | 15 | 15.41 | 15.4 | 16.95 | 17.41 | 25.78 |
| Pre Tax Margin(%) | 5.37 | 7.78 | 9.13 | 13.53 | 13.02 | 13.88 | 13.92 | 15.6 | 15.66 | 24.75 |
| PAT Margin (%) | 4.1 | 5.66 | 6.1 | 9.01 | 8.84 | 9.55 | 9.56 | 10.56 | 10.17 | 20.28 |
| Cash Profit Margin (%) | 7.73 | 8.55 | 8.58 | 11.03 | 11.03 | 12.01 | 12.2 | 13.26 | 12.93 | 22.99 |
| ROA(%) | 3.96 | 6.11 | 7.24 | 10.8 | 10.51 | 11.26 | 10.05 | 10.13 | 10.78 | 22.51 |
| ROE(%) | 13.1 | 19.26 | 22.72 | 32.76 | 27.45 | 25.52 | 22.33 | 23.37 | 25.06 | 44.11 |
| ROCE(%) | 12.19 | 17.02 | 20.32 | 27.56 | 25.07 | 25.3 | 23.99 | 24.46 | 28.51 | 43.95 |
| Receivable days | 62.23 | 63.74 | 62.84 | 62.91 | 66.71 | 65.99 | 63.2 | 64.58 | 59.6 | 58.24 |
| Inventory Days | 77.66 | 60.19 | 56.43 | 58.98 | 54.17 | 46.63 | 58.8 | 57.42 | 41.16 | 34.81 |
| Payable days | 70.27 | 58.85 | 61.27 | 69.96 | 65.55 | 63.81 | 92.13 | 85.74 | 79.88 | 77.91 |
| PER(x) | 6.28 | 4.99 | 6.53 | 5.87 | 14.05 | 12.8 | 17.74 | 18.71 | 19.87 | 12.2 |
| Price/Book(x) | 1.04 | 0.9 | 1.37 | 1.7 | 3.46 | 3.08 | 3.59 | 4 | 4.53 | 4.6 |
| Dividend Yield(%) | 3.49 | 4.65 | 3.23 | 3.21 | 1.29 | 3.18 | 1.11 | 1.16 | 0.95 | 1.66 |
| EV/Net Sales(x) | 0.88 | 0.69 | 0.79 | 0.85 | 1.59 | 1.54 | 2.07 | 2.29 | 2.19 | 2.53 |
| EV/Core EBITDA(x) | 6.24 | 4.43 | 4.91 | 4.37 | 8.55 | 7.97 | 10.76 | 11.71 | 11.13 | 9.52 |
| Net Sales Growth(%) | 9.7 | 22.03 | 27.11 | 21.93 | 6.78 | 1.52 | 3.52 | 23.08 | 37.36 | 17.31 |
| EBIT Growth(%) | -14.45 | 51.15 | 35.46 | 57.98 | 0.17 | 4.17 | 3.46 | 26.94 | 39.07 | 73.77 |
| PAT Growth(%) | -6.15 | 68.45 | 38.16 | 79.49 | 5.34 | 9.52 | 3.72 | 27.37 | 30.46 | 133.81 |
| EPS Growth(%) | 9.19 | 26.08 | 37.61 | 78.73 | 4.3 | 10.86 | 3.56 | 27.37 | 30.46 | 133.81 |
| Debt/Equity(x) | 1.43 | 1.27 | 1.27 | 1.01 | 0.73 | 0.54 | 0.47 | 0.59 | 0.43 | 0.16 |
| Current Ratio(x) | 1.11 | 1.16 | 1.23 | 1.31 | 1.35 | 1.38 | 1.4 | 1.33 | 1.26 | 1.91 |
| Quick Ratio(x) | 0.59 | 0.74 | 0.77 | 0.85 | 0.88 | 0.94 | 0.71 | 0.85 | 0.83 | 1.37 |
| Interest Cover(x) | 2.32 | 2.98 | 3.82 | 6.31 | 7.57 | 10.04 | 10.36 | 12.54 | 9.98 | 24.97 |
| Total Debt/Mcap(x) | 1.37 | 1.4 | 0.92 | 0.59 | 0.21 | 0.17 | 0.13 | 0.15 | 0.1 | 0.03 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.96 | 71.97 | 71.96 | 72 | 72.04 | 72.03 | 72.03 | 72.03 | 72.05 | 72.04 |
| FII | 3.04 | 3.1 | 3.2 | 3.23 | 3.23 | 3.25 | 3.43 | 3.46 | 3.45 | 3.49 |
| DII | 1.1 | 1.07 | 1.53 | 1.76 | 2.18 | 2.61 | 2.88 | 3 | 3.01 | 3.11 |
| Public | 23.9 | 23.86 | 23.31 | 23 | 22.55 | 22.1 | 21.66 | 21.51 | 21.49 | 21.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 |
| FII | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 | 0.18 | 0.18 | 0.18 | 0.18 |
| DII | 0.06 | 0.05 | 0.08 | 0.09 | 0.11 | 0.13 | 0.15 | 0.15 | 0.15 | 0.16 |
| Public | 1.22 | 1.22 | 1.19 | 1.18 | 1.15 | 1.13 | 1.11 | 1.1 | 1.1 | 1.09 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +17% | +26% | +16% | — |
| Operating Profit CAGR | +58% | +40% | +24% | — |
| PAT CAGR | +134% | +57% | +34% | — |
| Share Price CAGR | -8% | -9% | -15% | +30% |
| ROE Average | +44% | +31% | +28% | +26% |
| ROCE Average | +44% | +32% | +29% | +25% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.96 | 71.97 | 71.96 | 72 | 72.04 | 72.03 | 72.03 | 72.03 | 72.05 | 72.04 |
| FII | 3.04 | 3.1 | 3.2 | 3.23 | 3.23 | 3.25 | 3.43 | 3.46 | 3.45 | 3.49 |
| DII | 1.1 | 1.07 | 1.53 | 1.76 | 2.18 | 2.61 | 2.88 | 3 | 3.01 | 3.11 |
| Public | 23.9 | 23.86 | 23.31 | 23 | 22.55 | 22.1 | 21.66 | 21.51 | 21.49 | 21.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 | 3.68 |
| FII | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 | 0.18 | 0.18 | 0.18 | 0.18 |
| DII | 0.06 | 0.05 | 0.08 | 0.09 | 0.11 | 0.13 | 0.15 | 0.15 | 0.15 | 0.16 |
| Public | 1.22 | 1.22 | 1.19 | 1.18 | 1.15 | 1.13 | 1.11 | 1.1 | 1.1 | 1.09 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.